Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Low molecular weight heparins].

A Kher, L Bara, M Samama

    Pathologie-Biologie
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Low molecular weight heparins show promising antithrombotic effects by targeting initial coagulation stages, with reduced bleeding and longer action than standard heparin. These heparins may also decrease heparin-induced thrombocytopenia risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti A/B Antibody Titer Rebound: Are we Making it Worse? Be Aware of Your Intravenous Immunoglobulin.

    Indian journal of nephrology·2018
    Same author

    Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants.

    British journal of anaesthesia·2018
    Same author

    Allocation Based on Virtual Crossmatch Alone: Not Yet Ready for Primetime.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
    Same author

    Optimizing twice weekly dialysis-converting two-star into five-star treatment?

    Indian journal of nephrology·2015
    Same author

    Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.

    International journal of clinical practice·2013
    Same author

    Fever, abdominal pain and renal failure in a kidney transplant recipient.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
    Same journal

    Pathologie-biologie·2020
    Same journal

    Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

    Pathologie-biologie·2015
    Same journal

    [Not Available].

    Pathologie-biologie·2015
    Same journal

    Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

    Pathologie-biologie·2015
    Same journal

    Biological diagnosis of diabetes mellitus.

    Pathologie-biologie·2015
    Same journal

    Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

    Pathologie-biologie·2015
    See all related articles

    Area of Science:

    • Biochemistry
    • Pharmacology

    Context:

    • Heparin, a mixture of anionic polysaccharides, exerts anticoagulant effects by potentiating antithrombin III (AT III).
    • Only a portion of commercial heparin binds effectively to AT III, leading to the development of low molecular weight heparin (LMWH) fractions.
    • LMWH preparations exhibit potent anti-factor Xa activity, suggesting a role in inhibiting early coagulation cascade stages.

    Purpose:

    • To investigate the antithrombotic potential of low molecular weight heparins (LMWHs).
    • To compare the efficacy and safety profile of LMWHs with standard heparin.
    • To explore the pharmacokinetic properties and clinical utility of LMWHs.

    Summary:

    • LMWHs demonstrate antithrombotic effects, potentially by inhibiting early coagulation factors, and show reduced bleeding complications compared to standard heparin.

    Related Experiment Videos

  • While anti-Xa activity is a key feature, it doesn't solely predict antithrombotic efficacy, as evidenced by studies on very low molecular weight fractions.
  • LMWHs may offer additional benefits, including enhanced fibrinolysis, reduced platelet interaction, and a lower risk of heparin-induced thrombocytopenia.

    • Impact:

    • LMWHs present a potentially safer and more effective alternative to standard heparin for antithrombotic therapy.
    • Improved pharmacokinetic profiles, including higher bioavailability and longer duration of action, allow for less frequent dosing.
    • Preliminary clinical data suggest LMWHs are effective in preventing post-operative thrombosis with once-daily administration.